Biotronik SE has been granted a patent for an implantable medical device that activates diagnostic or therapeutic functions only after specific criteria are met, such as time periods or passing a function test. The device can perform functions like cardiac defibrillation and antitachycardia stimulation. GlobalData’s report on Biotronik SE gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Biotronik SE, Neuromodulation implants was a key innovation area identified from patents. Biotronik SE's grant share as of May 2024 was 39%. Grant share is based on the ratio of number of grants to total number of patents.
Implantable medical device with sequential diagnostic/therapeutic functions
A recently granted patent (Publication Number: US11998749B2) discloses an implantable medical device that includes a processor and a memory unit with a computer-readable program. The program instructs the processor to detect when the device is implanted and activate specific diagnostic or therapeutic functions in a sequential manner. The second function is only activated after passing a function test and a specified time period has elapsed from the activation of the first function or the detection of implantation. These functions may include cardiac defibrillation, antitachycardia stimulation, and algorithm adaptation for stimulation. The patent covers various types of implantable devices such as pacemakers, cardioverter-defibrillators, and spinal cord stimulators, among others.
Furthermore, the patent details methods for controlling the operation of the implantable medical device, a computer program product to facilitate the functions described, and a method for implanting the device into a patient. The implantation process involves detecting the device's implanted state, activating diagnostic or therapeutic functions, and ensuring the sequential activation of these functions based on specific criteria. The functions encompass a range of cardiac-related activities, including electrode diagnostics, signal detection, and remote monitoring. The patent aims to enhance the efficiency and effectiveness of implantable medical devices by providing a structured approach to activating and managing diagnostic and therapeutic functions in a controlled manner, ultimately benefiting patients in need of such devices.
To know more about GlobalData’s detailed insights on Biotronik SE, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
